Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2010
09/23/2010US20100239544 Methods of treatment using electromagnetic field stimulated stem cells
09/23/2010US20100239543 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
09/23/2010US20100239540 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
09/23/2010US20100239532 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239503 Calcium-binding agents induce hair growth and/or nail growth
09/23/2010US20100239501 Gene sensitive to bone/joint disease and use thereof
09/23/2010CA2755797A1 Improved chemical synthesis of diazaindoles by chichibabin cyclization
09/22/2010EP2230308A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230232A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229390A1 Novel imidazoý1,2-a¨pyridine and imidazoý1,2-b¨pyridazine derivatives
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010CN101842390A Antibodies against RAMP3
09/22/2010CN101842385A Food material for inhibiting the formation of osteoclast
09/22/2010CN101842373A 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
09/22/2010CN101842362A Benzothiazole compounds
09/22/2010CN101842104A Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound
09/22/2010CN101842086A Alpha adrenergic receptor agonists for treatment of degenerative disc disease
09/22/2010CN101842026A Bone-strengthening food material
09/22/2010CN101838329A Anti-angiogenesis fusion protein
09/22/2010CN101838254A L-arginine derivative epimedium herb flavone combination and preparation method thereof
09/22/2010CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases
09/22/2010CN101837120A Method for orally administering parathyroid hormone (PTH)
09/22/2010CN101837115A Steamed and applied traditional Chinese medicine for promoting recovery after restoration of prolapse of lumbar intervertebral disc
09/22/2010CN101837105A Chinese medicinal composition preparation, preparation method and quality detection method
09/22/2010CN101837093A Chinese medicinal composition for curing gout
09/22/2010CN101837081A Specific analgesic patch
09/22/2010CN101837080A Oolong spur eliminating paste
09/22/2010CN101837079A Anti-inflammatory analgesic or anti-inflammatory immune medicinal composition, preparation method and application thereof
09/22/2010CN101837042A Preparation method of Flos albiziae wine
09/22/2010CN101836978A Solid preparation containing single crystal form
09/22/2010CN101836889A Biological hollow cancellous bone screw
09/22/2010CN101317942B Bone-setting alcohol
09/22/2010CN101259255B Externally-applied medicament for treating wrick
09/22/2010CN101181410B Chinese medicine prescription orally taken for curing osteosporosis
09/22/2010CN101172103B Medicament for treating multiple diseases such as climacteric syndrome and osteoporosis of women
09/21/2010US7799832 Especially tolperisone or its analogs eperisone or silperisone, or riluzole, propafenone, lidocaine, flecainide or metixen or their salts; treating pains which are accompanied by an increase in muscle tone
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799794 Treatment for cardiovascular disease
09/21/2010US7799791 osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalemia, bone disorders, bone cancer, metastasis pain; e.g. N-(1-cyclopentyl-2-(6-methoxy-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)-2-oxoethyl)-4-(2-(4-methylpiperazin-1-yl)thiazol-4-yl)benzamide
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate
09/21/2010US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
09/21/2010CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
09/21/2010CA2449521C Pharmaceutical formulation, its use, and method for its manufacture
09/21/2010CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/16/2010WO2010104577A2 Methods and kits for treating joints and soft tissues
09/16/2010WO2010104576A1 Methods for treating joints and discs with a carrier matrix and cells
09/16/2010WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010WO2010104187A1 Steroid compound
09/16/2010WO2010104079A1 Composition for reducing bone fracture risk and/or preventing bone fracture
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103843A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103429A1 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
09/16/2010WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
09/16/2010WO2010102825A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
09/16/2010US20100234966 Bone repair or augmentation device
09/16/2010US20100234470 Instillation Administration of Capsaicinoids for the Treatment of Pain
09/16/2010US20100234449 Immunostimulatory Method
09/16/2010US20100234448 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100234441 Novel compounds
09/16/2010US20100234440 Novel crystal of substituted phenylalkanoic acid ester and process for producing the same
09/16/2010US20100234435 Cycloalkylamino acid derivatives
09/16/2010US20100234416 Use of huperzine for disorders
09/16/2010US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
09/16/2010US20100234404 P-38 Kinase Inhibitors
09/16/2010US20100234382 Composition comprising a pde4 inhibitor and a pde5 inhibitor
09/16/2010US20100234373 Bis-aryl amide compounds and methods of use
09/16/2010US20100234367 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010US20100234356 Compounds useful as chemokine receptor antagonists
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234334 Nitric oxide releasing steroids
09/16/2010US20100234326 Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition
09/16/2010US20100234322 Treatment of osteoarthritis
09/16/2010US20100234317 Use of difructose anhydride-containing composition
09/16/2010US20100234296 Food material for inhibiting osteoclastogenesis
09/16/2010US20100234295 Treating Alzheimer's Disease And Osteoporosis And Reducing Aging
09/16/2010US20100234277 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease
09/16/2010US20100233810 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100233722 Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA
09/16/2010US20100233290 Use of difructose anhydride-containing composition
09/16/2010US20100233269 Mineralized polymer particles and the method for their production
09/16/2010US20100233247 Dressing Material Comprising Active Substances
09/16/2010US20100233234 System and method for a hydrogel and hydrogel composite for cartilage repair applications
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233158 Induction of immune tolerance
09/16/2010US20100233155 Humanized anti-ccr2 antibodies and methods of use therefor
09/16/2010US20100233154 Targeted binding agents directed to heparanase and uses thereof 463